Tiragolumab with atezolizumab for treating locally advanced unresectable stage 3 non-small-cell lung cancer after at least 2 cycles of platinum-based chemoradiation [ID6250]

• In development
• Reference number: GID-TA11278
• Expected publication date: TBC